Clindamycin 300 Mg Capsules

₹ 2,490/Box

Strength300 mg
Pack Size10 capsules
BrandAbbott
FormCapsule
Dosage FormCapsule
Prescription TypePrescription
Packaging TypeBox
Shelf life24 months
Country of OriginMade in India
AvailabilityIn Stock
View in Hindi क्लिंडामाइसिन 300 एमजी कैप्सूल
Clindamycin is indicated for the treatment of: Serious infections caused by anaerobic bacteria, including intra-abdominal infections, skin and soft tissue infections. As needed, clindamycin should be administered in conjunction with another antibacterial agent that is active against gram negative aerobic bacteria.

Find products similar to Clindamycin 300 Mg Capsules

Find related categories

Shipping Information

PriceExcluding all taxes
ShippingAs per delivery location

Product Image

Clindamycin 300 Mg Capsules image 1Clindamycin 300 Mg Capsules image 2Clindamycin 300 Mg Capsules image 3Clindamycin 300 Mg Capsules image 4Clindamycin 300 Mg Capsules image 5Clindamycin 300 Mg Capsules image 6Clindamycin 300 Mg Capsules image 7Clindamycin 300 Mg Capsules image 8Clindamycin 300 Mg Capsules image 9Clindamycin 300 Mg Capsules image 10Clindamycin 300 Mg Capsules image 11

About the Company

GST Registration Date
Dec 2021
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
June 2022
GST
04**********1ZT

Established in the year of 2021, We Rg Lifesciences are Trader, Wholesaler And Distributor of Pharmaceutical Capsules, Pharmaceutical Syrup, Pharmaceutical Tablets, Protein Powder, Energy Drink Powder.We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers. 

For our accomplishment story, we are grateful to our Mr. Chandresh Vishwakarma ,whose continual backing and direction have been useful to us for attaining exponential development in the current market.